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Hepatitis C virus (HCV) is a single-stranded RNA virus and its genome is translated into a single large polyprotein. The
viral-encoded NS3 protein possesses protease, nucleoside triphosphatase, and helicase activities. Since these activities
appear to be important for viral replication, efforts are being made to identify compounds that might inhibit the enzymatic
activities of NS3 and serve as potential anti-HCV agents. We used a genetic selection strategy in vitro to isolate, from a
pool of completely random RNA (120 random bases), those RNA aptamers that could bind to NS3. After six cycles of
selection and amplification, 14% of the pooled RNAs could bind specifically to the NS3 protein. When the aptamers in the
pool (cycle 6) were analyzed for binding and inhibition of the proteolytic activity of NS3 with the NS5A/NS5B peptide as
substrate (S1), two aptamers, designated G6–16 and G6 –19 RNA, were found to inhibit NS3 in vitro. Kinetic studies of the
inhibition revealed that the aptamer G6–16 inhibited the NS3 protease with an inhibitory constant (Ki) of 3 mM. We also
analyzed aptamers G6–16 and G6–19 for their action with a longer protein substrate (amino acid region 2203–2506) and
found that these aptamers efficiently inhibited the proteolytic activity of NS3. In addition, both G6–16 and G6–19 aptamers
were found to inhibit the helicase activity of NS3. Since these aptamers possesses dual inhibitory function for NS3, they
could prove to be useful as anti-HCV drug leads. q 1997 Academic Press
INTRODUCTION to E2) are generated by the action of host cell proteases
(Houghton, 1996; Rice, 1996).
The hepatitis C virus (HCV) is the major causative Studies using both a transient-coexpression system in
agent of both sporadic and post-transfusion non-A, non- animal cells and an assay of coupled transcription and
B hepatitis (Choo et al., 1989; Kuo et al., 1989). Infection translation in vitro demonstrated that at least two virally
by HCV frequently leads to persistent liver infection and encoded proteins, a metalloprotease (NS2–3) and a serine
HCV has been implicated in the vast majority of cases protease (NS3), are responsible for the proteolytic cleav-
of acute hepatitis, chronic hepatitis, and liver cirrhosis ages in nonstructural regions of the polyprotein (Bar-
(Shimotohno, 1993). The HCV genome is a single- tenschlager et al., 1994; Francki et al., 1991; Hahm et al.,
stranded RNA about 9.5 kb in length. Sequence analysis 1995; Hijikata et al., 1993; Hirowatari et al., 1993; Lin et al.,
1994a, 1995; Mizushima et al., 1994a). The amino terminusof the genome indicates that there is a 5* untranslated
of the NS2–3 region encodes a novel Zn2/-dependent pro-region (341 nt), a single open reading frame that encodes
tease that is responsible for the cleavage between NS2a polyprotein (of about 3010 amino acids), and a 3* un-
and NS3. The NS3 protease has a serine protease domaintranslated region (Fig. 1A). The precursor polyprotein
in the amino-terminal region of 180 amino acids and a( NH2 – C – E1 – E2A / E2B – p7 – NS2 – NS3 – NS4A – NS4B –
helicase domain in the carboxy-terminal region (GrakouiNS5A–NS5B–COOH) releases 10 viral proteins after
et al., 1993b; Hijikata et al., 1993; Hirowatari et al., 1993; Kimproteolytic processing by both host cell and virally en-
et al., 1995; Satoh et al., 1995). The NS3 serine protease iscoded proteases (Grakoui et al., 1993a; Hijikata et al.,
essential for the maturation of the NS3, NS4A, NS4B, NS5A,1991, 1993; Hirowatari et al., 1993; Lin et al., 1994a).
and NS5B nonstructural proteins (Hijikata et al., 1993; TanjiRecent results have shown that the structural proteins (C
et al., 1993; Tomei et al., 1993). The residues His-1083,
Asp-1107, and Ser-1165 in NS3 form the catalytic triad of
the serine protease domain (Kato et al., 1990; Tanaka et1 Present address: Department of Obstetrics and Gynecology, Univer-
sity of Texas Medical Branch, Galveston, TX 77555–1062. al., 1992). The NS3/NS4A site is cleaved in cis by the
2 Present address: Institute for Virus Research, Kyoto University, Ky- NS3 protein, whereas the cleavages at NS4A/NS4B, NS4B/
oto 606-01. NS5A, and NS5A/NS5B sites occur in trans. Recent results3 To whom correspondence should be addressed: National Institute
suggest that NS3 alone is insufficient for efficient cleavageof Bioscience and Human Technology, MITI, AIST, 1-1 Higashi, Tsukuba
of the polyprotein and that NS4A is required as a proteinScience City, Ibaraki 305, Japan. Fax: 81–298–54–6095. E-mail:
nisikawa@ nibh.go.jp. cofactor that can be provided either in trans or in cis (Failla
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FIG. 1. Schematic representation of the polyprotein of HCV and the locations of the structural and nonstructural proteins. Numbering of amino
acids is that of Kato et al. (1990). (A) The NS3 protease cleaves the polyprotein at four sites (arrows). The peptide representing the NS5A/NS5B
junction was used to analyze the proteolytic activity in vitro (bold arrow). (B) MBP-NS3 fusion protein used in the present study. (C) Histidine-tagged
truncated NS3 (DNS3) protein containing the protease domain of the NS3. (D) Sequence of the 169-mer RNA with a core of 120 random bases
(bold letters), flanked by the primers (shown in italics).
et al., 1994, 1995; Satoh et al., 1995; Shimizu et al., 1996; the occurrence of two domains (protease and NTPase/
helicase) in NS3 may simply reflect economical packag-Tanji et al., 1995). The NS4A protein is essential for the
cleavage at the NS4B/NS5A junction and it also plays a ing of essential replicative viral components, their activi-
ties are also interdependent. Consistent with the aboverole in enhancing the processing at other cleavage sites
(Shimizu et al., 1996). notion, recently, Morgenstern et al. (1997) showed that
poly(U) increases the protease and NTPase activitiesThe C-terminal two-thirds of NS3 protein encodes a
helicase domain (Grakoui et al., 1993b; Hijikata et al., while inhibiting the helicase activity. Based on this obser-
vation they opined that NS3 binding to poly(U) decouples1993; Hirowatari et al., 1993; Kim et al., 1995; Satoh et
al., 1995). It contains conserved sequence motifs charac- the NTPase and helicase activities, thus leading to
upregulation of the physiological mechanism of polypro-teristic of NTP-binding proteins and also possesses sig-
nature sequences, the so-called D-E-A-D superfamily of tein processing. Since the NS3 protein has diverse func-
tions in the HCV life cycle, it is an important and attractiveRNA helicases (Lain et al., 1989; Linder et al., 1989). The
nucleoside triphosphatase (NTPase) activity of NS3 has target to develop anti-HCV therapy.
A recently strategy developed for genetic selection inbeen characterized by using both full-length NS3 protein
(containing amino acids 1027–1658) (Houghton, 1996) vitro has allowed the isolation of nucleic acids that can
bind target molecules with high affinity and specificityand truncated NS3 protein (containing only the helicase
domain) (Jin and Peterson, 1995; Suzich et al., 1993). (for recent reviews, see Gold et al., 1995; Gold, 1995;
Uphoff et al., 1995). The strategy involves isolation of rareSimilarly, the helicase activity for the above full-length
and truncated NS3 proteins was also characterized nucleic acid molecules that have high affinity for a target
molecule from a pool of random nucleic acids, with sub-(Houghton, 1996; Kim et al., 1995). Despite the fact that
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sequent repeated rounds of selection and amplification. In vitro selection of NS3-binding aptamers
This procedure has proved to be extremely useful for the
To eliminate RNAs that bound to the filter, RNAs wereisolation of tight-binding oligonucleotide ligands (ap-
passed three times prior to each selection cycle throughtamer) for a number of target molecules, such as nucleic
prewetted nitrocellulose acetate filters (HAWP filter, 0.45acid-binding proteins, non-nucleic acid-binding proteins,
mm, 13.0-mm diameter, Millipore) in ‘‘Pop-top’’ filter hold-and certain small molecules.
ers (Nucleopore). To reduce the chance of obtaining theIn our initial attempt to isolate RNA aptamers that bind
10G-1 RNA-like motif, which had been selected with theto NS3 protein, we used a constrained RNA library of se-
12N–18N random pool, in the present selections we al-quences with a short random tract of 12–18 bases that
lowed the 120N pool to compete with 10G-1 RNA in addi-was designed to represent all possible sequence variants
tion to the nonspecific competitor (tRNA). For the firstduring selections and obtained an aptamer that binds to
cycle of selection, approximately 4 1 1013 RNA se-the NS3 with lower affinity (Urvil et al., 1997). To isolate
quences (in the 120N pool) in binding buffer [50 mMmore efficient RNA aptamers for the NS3 protein of HCV,
Tris–HCl (pH 7.7), 30 mM NaCl, 5 mM CaCl2 , 10 mMin the present report, we adopted two different approaches:
dithiothreitol (DTT)] were denatured at 907 for 2 min and(i) we exploited a pool of longer random RNA sequences
allowed to cool at room temperature for 10 min to facili-(random tracts of 120 bases) since we expected such se-
tate the equilibration of different conformers. Similarly,quences may have greater structural complexity than the
the competitors, tRNA and the 12N–18N RNA pool, wereshorter random sequences (Conrad et al., 1996); and (ii) in
denatured independently in binding buffer and allowedeach selection cycle, we allowed the current pool (120N) to
to equilibrate. The RNAs were combined, NS3 wascompete with the specific competitor [an aptamer isolated
added, and the final mixture (0.5 mM MBP-NS3, 5.0 mMearlier that binds to the NS3 (Urvil et al., 1997)]. By combin-
120N pool RNA, and 5.0 mM 12N–18N RNA pool; molaring these two approaches during selection cycles, probably
ratio of protein to RNA, 1:20) in 50 ml of binding bufferone can effectively ensure removal of structural motifs that
was incubated at room temperature for 1 hr and filtered.were found in our earlier pool from the current pool; in
The filter was washed with 1 ml of binding buffer. Theaddition, other higher affinity RNA motifs can be isolated
RNAs that were retained on the filter were eluted twiceeffectively. After six cycles of selection and amplification,
with 200 ml of elution buffer (0.4 M sodium acetate, 514% of the pooled RNAs could bind specifically to the NS3
mM EDTA, and 7 M urea, pH 5.5) at 707 over the courseprotein. Two aptamer RNAs from the pool designated G6–
of 5 min. The eluates were combined and diluted with16 and G6–19 were found to bind efficiently to the NS3
400 ml of H2O before ethanol precipitation. Eluted RNAsprotein. These aptamers inhibited efficiently the proteolytic
from the filter were reverse-transcribed in 20 ml of aactivity in vitro using either a shorter or a longer substrate.
reaction mixture that contained 50 mM Tris–HCl (pH 8.0),These aptamers were also found to inhibit the helicase
40 mM KCl, 6 mM MgCl2 , 0.4 mM dNTPs, 2.5 mM primeractivity of NS3.
(24.169), and 5 U of AMV reverse transcriptase (Seika-
gaku). Nucleotides and enzyme were added after an an-MATERIALS AND METHODS
nealing step (2 min at 907 followed by incubation at room
Proteins and nucleic acids temperature for 10 min). Reverse transcription was car-
ried out for 1 hr at 427.The NS3 protein of HCV used for selections was puri-
For amplification by polymerase chain reaction (PCR),fied as a maltose-binding fusion protein (MBP-NS3), as
20 ml of the mixture after reverse transcription (cDNAdescribed previously (Fig. 1B; Kakiuchi et al., 1995). To
reaction mixture) was diluted in 80 ml of a mixture forevaluate the regions of the MBP-NS3 protein that bound
PCR [10 mM Tris-HCl (pH 8.8), 50 mM KCl, 1.5 mM MgCl2 ,aptamers, we constructed a truncated form of NS3
and 0.1% Triton X-100, 5 U of Taq DNA polymerase (Nip-[DNS3, amino acids 1027–1218 (Fig. 1C)] in a protein-
pon Gene), and 0.4 mM each of 24.169 and 39.169 prim-expression vector, pHisBDNS3, and expressed the trun-
ers]. The reaction mixture was cycled at 947 for 1.15 min,cated protein in Escherichia coli (Vishnuvardhan et al.,
at 507 for 1.15 min, and at 727 for 2.15 min for as many1997). Both forms of NS3 protein were purified (95%)
cycles as needed to produce a band of a product ofand used in our studies.
the correct size. The product of PCR was precipitated inThe RNA pool (169.1) for use in selections was as
ethanol and used for transcription. Transcription in vitroinitially described by Ellington and Szostak (1992). Figure
was performed at 377 for 2 hr with a T7 Ampliscribe1D is a representation of the sequence, which contained
kit (Epicentre Technologies). After synthesis of RNA anda core of 120 random bases flanked by primers (shown
treatment with DNase I, the reaction mixture was frac-in italics). The primers used for the amplification of the
tionated on an 8% denaturing polyacrylamide gel. RNApool were 5*-AGTAATACGACTCACTATAGGGAGAAT-
was extracted from the gel and used for the next cycleTCCGACCAGAAG-3* (designated 39.169) and 5*-TGA-
of selection and amplification.GGATCCATGTAGACGCACATA-3* (designated 24.169).
A mutagenic PCR protocol (Leung et al., 1989) wasIn the selection cycles, yeast tRNA (Boehringer-Mann-
heim) was used as a nonspecific competitor. also employed at the seventh and eighth generation cy-
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TABLE 1 nally labeled RNA was prepared using 0.5 mCi/ml [a-
32P]CTP. Conditions for binding and in vitro transcriptionConcentrations of RNA and NS3 Protein Used in Selection Cycles
were similar to those used for selection except that theand Binding to NS3 of the Various Poolsa
molar ratio of RNA to NS3 was 1:1 (150 nM:150 nM). The
Concentrations (mM) Filter binding filters were washed with 1 ml of binding buffer and air-
assayd (% of dried, and radioactivity was quantitated with an image
NS3 Pool 10G RNA bound
analyzer (BAS2000, Fuji Film). To ensure that the bindingCycle proteinb RNA RNAc tRNA to NS3)
was specific, we added a 10-fold molar excess of tRNA
1 0.5 5.0 5.0 — 0.7 as a nonspecific competitor in the binding reaction. To
2 0.25 5.0 5.0 5.0 1.6 determine if the aptamers selected with the MBP-NS3
3 0.125 5.0 5.0 5.0 2.3 fusion protein were also selected with the protease do-
4 0.25 5.0 5.0 40.0 3.9
main of NS3, we performed a similar binding assay using5 0.063 1.0 2.5 30.0 4.7
a truncated NS3 (DNS3) protein that included only the6 0.021 0.3 0.8 10.0 13.9
7 0.013 0.2 0.5 6.0 9.7 protease domain.
8 0.011 0.18 0.45 5.5 8.2
Protease inhibition assay using synthetic substrate
a RNAs and NS3 protein were allowed to bind at room temperature
for 30 min in 50 ml of binding buffer [50 mM Tris–HCl (pH 7.7) 30 mM To determine the proteolytic activity of NS3 in vitro, we
NaCl, 5 mM CaCl2 , 10 mM DTT]. used, as substrate, the synthetic peptide S1 (17-mer:
b Concentrations of MBP–NS3 protein, with both a protease and a Dns – Gly – Glu – Ala – Gly – Asp – Asp – Ile – Val – Pro – Cys –
helicase domain (amino acid, 985–1647).
D–Ser–Met–Ser–Tyr–Thr–Trp–Thr-COOH; D  cleav-c Specific competitor (12–18 N pool).
age site) that spanned the NS5A/NS5B cleavage junctiond The filter binding assay was carried out in 50 ml of binding buffer
containing NS3 (150 nM), the RNA pool (150 nM), and tRNA (1.5 mM). (Kakiuchi et al., 1995). Prior to the cleavage reaction, the
MBP-NS3 protease and an aptamer RNA (G6–8, G6–12,
G6–16, or G6–19) or tRNA were preincubated at 257 for
cles. In these cycles, half of the cDNA reaction mixture 15 min. The inhibition assay was carried out in either the
was amplified as described above, while the remaining presence (1.6 mM) or the absence of an aptamer RNA or
half was amplified in 100 ml of a reaction mixture for tRNA in 25 ml of a binding buffer that contained MBP-
PCR that contained 67 mM Tris-HCl (pH 8.8), 16.6 mM NS3 (0.84 mM) and the substrate S1 (90 mM). The reaction
(NH4)2SO4 , 6.1 mM MgCl2 , 6.7 mM EDTA (pH 8.0), 0.17 mixture was then incubated at 257 for 1 hr and analyzed
mg/ml BSA, 10 mM b-mercaptoethanol, 1% DMSO, 0.2 as reported elsewhere (Kakiuchi et al., 1995).
mM dATP, 1 mM each of dCTP, dGTP, and dTTP, 0.5 mM To determine the inhibitory constant (Ki) for the G6–
MnCl2 , 5 U of Taq DNA polymerase, and 0.4 mM of each 16 RNA, we measured initial rates of proteolytic activity
primer. The reaction mixture was cycled at 947 for 1.15 at different concentrations of substrate (S1, 38–172 mM)
min, at 507 for 1.15 min, and at 727 for 2.15 min for as and G6–16 RNA (0.7–4.4 mM). All reactions were per-
many cycles as were needed to produce a band of a formed in 25 ml of binding buffer at 257 as mentioned
product of the correct size. The product from this PCR above. Aliquots were withdrawn and analyzed as de-
(ca. 0.25 mg) was combined with the product of the nor- scribed earlier (Kakiuchi et al., 1995). A Dixon plot of
mal PCR (ca. 1.0 mg) prior to transcription with T7 RNA 1/v (v  velocity) against the concentration of the RNA
polymerase. Subsequent selection cycles were similar was plotted and the Ki was calculated.
to the earlier ones with the exception that the stringency
of selection was increased to promote competition be- Inhibition of the proteolytic activity of NS3 by
tween binding species. Therefore, as the cycles pro- selected aptamers with a longer protein substrate
gressed the molar ratio of NS3 to RNA (including pool
The DNA fragment encoding amino acids 2203–2506RNA, nonspecific RNA, and specific competitor RNA) was
of the polyprotein (NS5A/NS5B, 43 kDa) was amplifiedincreased from 1:20 to 1:500 (Table 1).
by PCR from the parent vector pNS2–5. The sequences
of primers were as follows:
Analysis of aptamers and binding assay
5*-end primer AGTAATACGACTCACTATAGGGAGA
To obtain the individual aptamers, DNA after PCR from
CCGTGCATCATGAGCGCTAGCCAGTTGTCTGCGcycle 6 was directly ligated into the pCRII vector (In-
vitrogen) in accordance with the protocol provided by CCTTCTTTGAAG-3*;
Invitrogen. DNA was isolated from individual clones by
3*-end primer 5*-CGGTCAgtgatggtgatggtgatgthe alkaline-lysis method and sequenced with a Dye Ter-
minator Sequencing Kit [Applied Biosystems Inc. (ABI)]
CTCCTCTATAGATAGAAGCCTAGCCTTAAC-3*
on a DNA sequencer (Model 373A, ABI). For evaluation
of the binding activities of pool RNAs from different selec- Italic letters indicate sequences of HCV, the T7 promoter
sequence is underlined, the stop codon is shown bytion cycles, as well as those of individual aptamers, inter-
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outlined letters, lowercase letters encode (His)6 , and reaction volume of 50 ml for 30 min at ambient tempera-
ture. The reaction mixture was filtered through the mem-boldface letters show the IRES (internal ribosome entry
site) of HCV, as defined previously (Hijiakata et al., 1993; brane HAWP filter and the RNA fragments retained on
the filter were recovered using elution buffer (200 ml) atHirowatari et al., 1993). The resulting product of PCR (ca.
1.0 mg) was added directly to 25 ml of the transcription 927 for 5 min. The eluted RNAs were extracted twice with
phenol and chloroform before ethanol precipitation. Theand translation TNT reaction mixture (Promega) and the
synthesis of NS5A/NS5B was allowed to proceed for 2 recovered RNA sample was resolved along with partially
digested markers on 8% denaturing PAGE. Partially di-hr at 307 in the presence of [35S]methionine (Amersham).
The protease assay was carried in 10 ml of solution gested samples were prepared using specific ribo-
nucleases under conditions similar to those reported bywith freshly translated substrate NS5A/5B (43-kDa pro-
tein). G6–16, G6–19, and tRNA were denatured indepen- Jeoung et al. (1994).
dently in buffer [50 mM HEPES (pH 7.6), 3 mM MgCl2 , 1
Equilibrium dissociation constants (Kd values)mM DTT] and allowed to equilibrate as described above.
To samples of RNA (4 mM), we added MBP-NS3 protein Internally labeled RNAs of both G6–16 (167 mer) and
DG6–16 (113 mer) were prepared by in vitro transcription.(1.5 mM) and preincubated the mixture for 15 min in the
same buffer. The cleavage reaction was initiated by add- Transcription reaction was carried out in the presence of
0.5 mCi/ml [a-32P]CTP. Full-length transcripts were puri-ing 3 ml (ca. 150 cpm) of newly synthesized NS5A/5B
substrate (TNT lysate). The reaction mixture was incu- fied by polyacrylamide gel electrophoresis under denatur-
ing conditions. After recovering the labeled RNAs from thebated at 257 for 2 hr and stopped by addition of an equal
volume of sample buffer. After denaturation at 907 for 5 gel, the RNA samples were initially denatured at 927 for
2 min in binding buffer and equilibrated for 10 min atmin, the mixture was fractionated by SDS–PAGE on 15%
polyacrylamide gel. Inhibition by aptamers was quanti- ambient temperature. RNA samples (50 nM) were incu-
bated with varying amounts of either MBP-NS3 or DNS3tated in terms of the amount of uncleaved substrate that
remained. protein in 50 ml binding buffer containing a 10-fold excess
of tRNA. RNA–protein complexes were separated through
Gel-shift assay the prewet HAWP filters and the filters were washed with
1 ml of binding buffer. The radioactivity retained on filters
The aptamer (G6–16 RNA, 20 pmol) was dephosphory-
was quantitated directly using BAS2000 (Fuji Film). The
lated with alkaline phosphatase (Takara) prior to treat-
amount of RNA bound to the NS3 proteins was calculated
ment with T4 polynucleotide kinase (Takara) under the
as a percentage of input RNA prior to filtration. The data
conditions reported earlier (Jeoung et al., 1994). The ra-
points obtained were fitted to a Scatchard plot for determi-
diolabeled aptamer (4 1 104 cpm, 0.23 pmol), was mixed
nation of the equilibrium dissociation constant.
with MBP-NS3 protein (75 pmol) in binding buffer and
the mixture was incubated at room temperature for 30 Analysis of the ATPase activity of MBP-NS3 in the
min. The mixture was then combined with glycerol (5%, presence of G6–16 aptamer
v/v), loaded onto a 3.6% nondenaturing polyacrylamide
For the controls, measurement of the hydrolysis of [g-
gel (acrylamide:bis, 79:1, w/w), in buffer [50 mM Tris – 32P]ATP was carried out in reaction mixtures (10 ml) con-
HCl (pH 8.0), 380 mM glycine, 2 mM EDTA, 5% glycerol],
taining 50 mM Tris–HCl (pH 7.5), 2 mM DTT, 5 mM ATP,
and subjected to electrophoresis at 8 mA in 0.51 TBE
1 mCi [g-32P]ATP, 5 mM MgCl2 , 0.5 mg/ml BSA, and 300at 257 for 4.5 hr. The amount of complex formed was
nM MBP-NS3. For the test samples, varying concentra-
quantitated with the image analyzer. To ensure that the
tions of G6–16 aptamer was initially denatured in buffer
interaction between the selected aptamer and the protein
[50 mM Tris–HCl (pH 7.5), 5 mM MgCl2] and equilibratedwas specific (G6–16 RNA:NS3), we also examined the
for 10 min at ambient temperature before mixing with
formation of the complex in the presence of 150 mM
300 nM MBP-NS3. The ATPase reaction was initiated by
NaCl and a 10-fold excess of tRNA over the aptamer.
the addition of substrate in both controls and test sam-
ples. The reaction mixtures were incubated for either 30Analysis of minimal 3*-end sequence requirements of
or 60 min at 307 and aliquots (1.5 ml) were collected atG6–16 for efficient binding to the MBP-NS3
20- and 40-min intervals. These samples were spotted
onto PEI (Polyethyleneimine, Macherey-Nagel) platesTo define the minimal 3*-end sequence of G6–16 that
is required for efficient binding to the NS3 protein, tran- and separated by chromatography in 0.35 M potassium
phosphate. The regions containing ADP and Pi werescripts of G6–16 were initially dephosphorylated with
calf intestinal phosphatase (Takara) followed by 5*-end quantitated with an image analyzer (BAS2000, Fuji Film).
labeling using polynucleotide kinase (Takara); the details
Inhibition of the helicase activity of MBP-NS3of the conditions for these reactions are reported else-
by G6–16 aptamerwhere (Jeoung et al., 1994). The partially hydrolyzed la-
beled G6–16 (8 1 105 cpm) RNA was incubated with We have measured the unwinding activity of helicase
on DNA duplex that corresponds to the 3*-end se-MBP-NS3 protein (18 pmol) in binding buffer in a final
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quences of HCV genome (Tai et al., 1996). The DNA 49 of the clones were sequenced, and the corresponding
aptamers were assayed for binding, in the presence oftemplates were chemically synthesized [T53, 5*-ACATTA-
TGCTGAGTGATATCCCGGAAGAAACCACCGAGGTAG- tRNA, to the NS3 protein. The sequences of the high-
affinity aptamers (10% binding) were aligned intoAATCGGGATCA-3*; P35, 5*-AGGGCTAAGATCCTCGGT-
GGTTTCTTCCGGGATAT-3*] and purified on 15% PAGE. classes (Fig. 2A). The relative frequencies of these
groups in the pool were estimated to be 4–20%. BasedThe P35 oligo was initially labeled at the 5* end and
purified as reported (Jeoung et al., 1994). The DNA heli- on the sequence homology, the binding aptamers could
be divided into four groups (with more than 40% homol-case substrate was prepared by mixing 2.2 mM T53 and
0.2 mM P35 (containing 2 1 105 cpm labeled P35) in 10 ogy within each classes). After analyzing different se-
quences in each class, a conserved sequence of ele-ml of H2O followed by denaturation at 927 for 2 min. Under
these conditions the duplex formation was about 92%, ments for each class was identified (Fig. 2B). Representa-
tive aptamers were selected (G6–8, G6–12, G6–16, andbased on its mobility in native gel.
DNA helicase activity was determined on native gels G6–19) from each class based on their higher affinity
(10% and 10% binding ability) to NS3 as well as theirusing the above duplex substrate. RNA samples (1.6
mM)—oligo(A)20 , or oligo(U)20 , or G6–16, or G6–12 (a predominant presence. As seen from the Fig. 3 the ap-
tamers G6–16 and G6–19 had higher binding affinity forpredominant aptamer)—are initially denatured at 927 for
2 min in 25 mM MOPS– KOH (pH 6.5), 3 mM MnCl2 and MBP-NS3 (Fig. 3) compared with the other two groups.
Proposed secondary structures were drawn by Mulfoldequilibrated for 10 min at ambient temperature. To these
samples, 1.6 mM MBP-NS3 was added and equilibrated (Jaeger et al., 1989) of the aptamers that belonged to the
four groups and are shown in Fig. 3.for 10 min. The helicase reaction was initiated by the
addition of 1 ml of substrate in helicase buffer [25 mM
MOPS–KOH (pH 6.5), 3 mM MnCl2 , 10 mM DTT, 500 mg/ Inhibition of proteolytic activity by aptamers
ml BSA, 5 mM ATP] to a final reaction volume (10 ml).
Control reactions were also performed under similar con- Next, we evaluated individual aptamers from different
groups for the inhibition of proteolytic activity in vitro.ditions in either the presence or the absence of MBP-
NS3. The samples were incubated at 307 and 4.0-ml ali- Assays were performed with a chemically synthesized
peptide that spanned the NS5A/5B cleavage junction asquots were collected at 30- and 60-min intervals. The
reaction was stopped by the addition of 50 mM EDTA. the substrate, with MBP-NS3 as the enzyme (Kakiuchi et
al., 1995) and in the presence of aptamer G6–8, G6–The aliquoted samples were mixed with 2 ml of 50% glyc-
erol and loaded directly onto the 15% native gel. Electro- 12, G6–16, G6–19, or tRNA (control). Approximately 50%
inhibition was observed only with G6–16 and G6– 19phoresis was run at 15 mA for 2 hr in 0.51 TBE buffer.
(Fig. 4). Only moderate inhibition was observed in the
presence of G6–8. To our surprise, the predominant ap-RESULTS
tamer G6–12 did not inhibit the protease, a result that
Selection of RNA aptamers
was consistent with its weak binding to the DNS3 prote-
ase domain (Fig. 3).In the first selection cycle, about 1014 RNA sequences
were allowed to compete with the 12N–18N pool for To determine the nature of inhibition by the aptamer,
different concentrations of G6–16 were analyzed at vary-binding to the NS3 protein at a molar ratio of protein to
RNA of 1:20 in the binding buffer in which the proteolytic ing amounts of substrate (NS5A/5B junction peptide, 17-
mer peptide). The aptamer G6–16 inhibited the proteolyticactivity is routinely analyzed (Kakiuchi et al., 1995). In
subsequent cycles, molar ratios of NS3 and RNAs [120N activity of NS3 in a mixed manner (competitive and non-
competitive) from Dixon plot analysis (Fig. 5). The aptamerpool, 10G-1 RNA (specific competitor), and tRNA (non-
specific competitor)] were manipulated to increase the inhibited the protease activity with a Ki of 3 mM (Fig. 5).
From these results it appears that the aptamers (G6–16stringency of selection (Table 1). After two such cycles,
the RNA pool was assayed for its ability to bind to the and G6–19) bind to the protease domain of MBP-NS3.
To test directly the above possibility, we constructedNS3. As the cycles progressed, specific RNA aptamers
that bound to NS3 increased in the pool from 0.7% (first and expressed a protein that included only the protease
domain of NS3 [DNS3, amino acids 1027–1218 (Vishnu-cycle) to 14% (sixth cycle) of the total (Table 1). Since the
1014 variants in the 120N pool cannot encompass the vardhan et al., 1997)] and used this protein in binding
assays. Only aptamers G6–16 and G6–19 bound to theentire range of possible (1072) variants, mutagenic PCR
was introduced after the sixth cycle to increase the diver- protease domain of NS3, albeit with five- to eightfold
reduced affinity (Fig. 3). However, we cannot exclude thesity of functional molecules. However, by introducing mu-
tagenic PCR, the number of binding species in the pool possibility that the reduced binding of aptamers to DNS3
might also have been due to the loss of the overall re-was reduced, probably by mutating the critical residues,
and, therefore, we selected the sixth cycle for the analy- quired conformation in the truncated protein (DNS3).
In the above studies, the inhibition of proteolytic activ-sis of sequences.
Individual aptamers from the sixth cycle were cloned, ity by aptamers was evaluated with a chemically synthe-
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FIG. 3. Secondary structures of the aptamers, as drawn by the Mulfold program. *The filter binding assay was carried out with individual aptamers
in 50 ml of binding buffer containing NS3 (150 mM), an aptamer (G6–8, G6–12, G6–16, or G6–19), and a 10-fold molar excess of tRNA (1.5 mM).
#The binding assay was carried out with aptamers in the presence of DNS3. All other conditions were similar to those described above. ND, not
determined; —, 0.1% binding; //, 2% binding.
sized substrate (17-mer peptide) that spanned the cleav- labeled G6–16 was partially alkaline hydrolyzed and the
fragments were incubated with MBP-NS3 and passedage site NS5A/5B. To examine in further detail the ap-
tamers’ ability to inhibit cleavage of a more ‘‘natural’’ through the nitrocellulose filters. By this procedure, frag-
ments retained on the filter are assumed to have highersubstrate (amino acids 2203 – 2506), we assayed the
proteolytic activity of NS3 using a larger protein sub- affinities to MBP-NS3. When the eluted RNAs were ana-
lyzed on the 10% PAGE, only RNAs possessing regionsstrate that had been synthesized in a rabbit reticulocyte
lysate (TNT). In this assay also, aptamers G6 – 16 and 1–113 nts were retained on the filter (Fig. 8). These re-
sults suggest that the region 1–113 nts contains all majorG6 – 19 clearly inhibited the activity of the protease (Fig.
6). These results suggested that the aptamers were spe- elements for efficient binding to NS3 (Fig. 8, lane 3).
Next, we determined the equilibrium dissociation con-cific for the NS3 protease, even in the presence of other
cellular components in the lysate. stants for G6–16 and DG6–16 (1–113 nts) using a filter
binding assay. As seen from Fig. 9, G6–16 RNA appearsGel-shift analysis
to have higher affinity (Kd  120 { 18 nM) to MBP-NS3
The specificity of the binding of G6–16 RNA to NS3
protein, as well as the formation of the complex (in the
presence of more than a 10-fold excess of tRNA over the
aptamer of 150 mM NaCl), was investigated in terms of
shifts in electrophoretic mobility in a nondenaturing gel
(Fig. 7). The results showed that the aptamer G6–16 RNA
formed a stable complex with NS3 protein (Fig. 7, lane
3; 55% of input) and that excess tRNA and NaCl each
moderately reduced the amount of complex formed (Fig.
7, lanes 1 and 2, 37%). A study of complex formation in
a nondenaturing gel showed that aptamer G6–16 formed
only a single complex (G6–16:NS3), suggesting a stoichi-
ometry of 1:1 for binding. Similar results were also ob-
tained with the aptamer G6–19 (data not shown).
FIG. 4. Inhibition of the proteolytic activity of NS3 by selected aptamers.
The inhibition was examined with a 17-mer peptide that spanned theAnalysis of minimal 3*-end sequence requirements of
NS5A/NS5B cleavage site, as described under Materials and Methods.G6–16 RNA for NS3 binding
The percentage of control proteolytic activity was calculated as described
To analyze the minimal 3*-end sequence requirement elsewhere (Kakiuchi et al., 1995). The values are averages of results from
duplicate experiments. Experimental variations are indicated by error bars.of G6–16 RNA for binding to NS3 protein, the 5*-end
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FIG. 5. Dixon plot for inhibition by G6–16 RNA. Reactions were
carried out with substrate S-1 at 38 (h), 86 (n), and 172 (s) mM,
respectively. Other details are given under Materials and Methods. FIG. 7. Gel-shift assay for analysis of the formation of a complex
between NS3 and G6–16 RNA. To determine the specificity and stoichi-
ometry of binding of G6–16 RNA to NS3, labeled nucleoprotein com-
compared with DG6 – 16 (Kd  238 { 110 nM) RNA. De- plexes were separated from unbound RNAs by electrophoresis on a
nondenaturing gel. Lane 1, G6–16 RNA (4 1 104 cpm, about 15 nM)spite their different affinities to NS3, both aptamers were
/ 5 mM NS3 protein / NaCl (150 mM); lane 2, G6–16 RNA (4 1 104found to have higher affinity (Kd) in the nanomolar range.
cpm, about 15 nM) / 5 mM NS3 protein / tRNA (2.5 mM); lane 3, G6–However, when these aptamers were analyzed with re-
16 RNA (4 1 104 cpm, about 15 nM) / 5 mM NS3 protein; lane 4, G6–
spect to their affinity to DNS3 they showed lower affinity 16 RNA (4 1 104 cpm, about 15 nM). Electrophoresis was performed
(Kd  1.7 { 0.8 mM). From these results it appears that at 8 mA for about 4 h, and both the complex (C) and free RNA (F) were
visualized and analyzed with an image analyzer.both truncated and full-length G6–16 aptamers recog-
nize DNS3 with similar affinity. Nevertheless, DG6–16
RNA represents a minimal binding motif that binds as
its amino-terminal and carboxy-terminal ends, respec-efficiently as G6–16 RNA.
tively. It is believed that both protease and helicase do-
mains are vital for HCV proliferation. Thus, it is possibleEffects of aptamers on ATPase and helicase activities
that, during selection, helicase-binding aptamers mightof NS3
have been enriched in the pool RNA. The probability of
The NS3 protein used in the selections in the present such a phenomenon increases, especially when nucleic
study had the protease domain and helicase domain at acids bind preferentially to one domain (e.g., a helicase
domain, a known nucleic acid-binding region) as com-
pared with another domain (protease) in the same pro-
tein. In addition, protease-inhibiting aptamers, G6– 16
and G6–19 RNA, may also interfere with the ATPase and
helicase activities of NS3. It was therefore important to
analyze whether the higher-affinity aptamers, G6–12, (a
predominant aptamer), G6–16, and G6–19, inhibit the
other two activities, ATPase and helicase, of NS3.
We have analyzed both ATPase and helicase activities
of MBP-NS3 in either the presence or the absence of
aptamers. None of the selected aptamers could inhibit
the ATPase activity of NS3 in either the presence or the
absence of oligo(U)20 (data not shown). On the contrary,
the helicase activity of NS3 was completely inhibited in
the presence of 1.8 mM G6–12, G6–16, or G6–19 RNA
FIG. 6. Inhibition of the proteolytic activity of NS3 by selected aptam- (Fig. 10, lanes 4–6). Helicase activity of NS3 protein was
ers in a TNT lysate. The assay was carried out in a volume of 10 ml
also analyzed in the presence of 1.8 mM oligo(U)20 andwith 3 ml of TNT lysate which contained the freshly translated substrate,
oligo(A)20 , and it was found that oligo(U)20 efficiently in-NS5A/NS5B protein, 1.5 mM NS3 protease, and 4 mM aptamer (G6–16
or G6–19) or tRNA. Prior to the assay, RNAs were denatured, allowed hibited (90%) compared with oligo(A)20 , (37%) (data
to equilibrate, combined with protease, and preincubated for 20 min. not shown). Previously, a similar amount of inhibition was
The cleavage reaction was initiated by the addition of substrate and reported for NS3 protein by poly(A) and poly(U) RNA (Tai
incubated for 2 hr at 257C. The reaction products were analyzed by
et al., 1996). We could not determine the inhibitory effectsSDS–PAGE and subsequently visualized with an image analyzer, as
of aptamers at lower concentrations (1.8 mM) since thedescribed under Materials and Methods. Experimental variations are
indicated by error bars. MBP-NS3 helicase exhibits about 42% helicase activity
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FIG. 9. Binding data for G6–16 and truncated G6–16 RNAs. Labeled
RNAs were mixed with different amounts of either DNS3 or MBP-NS3
and the RNA:protein complexes were separated on filters (for details,
see Material and Methods). Radioactivity retained on the filter was
divided by the total number of counts in the reaction mixture. This ratio
was plotted against the concentration of NS3 in the mixture.
then, several drugs thought to inhibit the helicase activity
have been under active screening.
The proteae and helicase domains of NS3 are active
in the absence of one another in vitro (Tai et al., 1996;
Vishnuvardhan et al., 1997); however, there is no evi-
dence that they are separated by proteolytic processing
in vivo. For this reason, it is important to target the native
NS3 protein while screening inhibitors instead of the
truncated forms. Recently, the X-ray crystal structure of
the protease domain was resolved (Love et al., 1996).
However, it is not clear yet whether a similar structure
FIG. 8. Autoradiograph showing results from boundary experiments.
is retained even in the presence of helicase domain.Lane 1, digested with U2 ribonuclease (specific for ‘‘A’’ residues); lane
In other words, the structure of full-length NS3 remains2, digested with T1 ribonuclease (specific for ‘‘G’’ residues); lane 3 G6–
16 RNA fragments retained on the filter in the presence of NS3 (18 unknown.
pmol); lane 4 partial alkaline hydrolysis. Arrow indicates the 3*-terminal In the past, in vitro selected aptamers were shown to
G of G6–16 RNA. recognize various epitopes on the surface of proteins
and also efficiently bind to active sites of proteins (Brown
at 1.8 mM concentrations. Thus, based on these observa-
tions we suggest that a predominant aptamer, G6–12,
could efficiently inhibit the helicase activity alone,
whereas G6–16 and G6–19 aptamers efficiently inhibit
both protease and helicase activities of NS3 in vitro.
DISCUSSION
The protease domain of NS3 of HCV contains a trypsin-
like serine protease. Site-specific mutagenesis has sug-
gested that residues His-1083, Asp-1107, and Ser-1165
form the catalytic triad of the protease domain. Since the
NS3 protein is vital for the proliferation of HCV, several FIG. 10. Helicase activity of NS3. Unwinding activity was measured
on DNA duplex substrate (complex) under conditions described undergeneral inhibitors of serine proteases have been tested
Materials and Methods. Control reactions were performed either in theas inhibitors of the proteolytic activity in vitro. However,
absence of NS3 (lanes 1 and 2) or in the presence of NS3 (lane 3).for inhibition, these inhibitors are required at millimolar
Inhibition of NS3 helicase activity by G6–12 (lane 4), G6–16 (lane 5),
concentrations (Lin and Rice, 1995). It is now believed and G6–19 (lane 6) RNAs was measured in the presence of NS3 protein
that not only the protease domain, but also the helicase (1.6 mM). Lane 7, the reaction did not contain NS3 and the substrates
were heat denatured.domain of NS3, is important in HCV replication; since
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and Gold, 1995; Conrad et al., 1994, 1996; Jellinek et al., important to evaluate the base residues of aptamers for
NS3 binding. Despite the fact that G6–16 and G6–191994; Kubik et al., 1994; Tuerk et al., 1992). Earlier, we
isolated an aptamer (10G-1) that bound to the NS3 pro- RNAs interfere with NS3 function at least in vitro, they
lack primary sequence homology. However, on close ex-tein specifically using a pool of RNAs with 12–18 random
bases. The selected aptamer binds to NS3, with Kd (of amination of their Mulfold structures and sequences, we
found that a five-base (AGGCT) stretch in the hairpin loopthe order of) 650 nM and also inhibits protease activity
inefficiently (20%) in vitro. We have taken advantage of was conserved in both aptamers. Interestingly, these se-
quences are located in the randomized region. Since10G-1 RNA, as well as longer random core pool (120N)
in the present study, to find alternate and more efficient RNA is known to interact with several ligands using sin-
gle-stranded regions or loop regions or bulge bases, weaptamers against the background of previously selected
predominant aptamers. Such larger randomized RNA suggest that the five-base stretch found in the loop region
of G6–16 and G6–19 aptamers may (be important inpools can generate more complex structures than small
randomized pools. Thus, the larger randomized pools addition to the above-mentioned common sequence ele-
ment) interact with another site in NS3 or interact withare preferable during selections, even though it is not
possible to include all sequence variants. other bases to attain an active structure. However, the
importance of this sequence has not yet been analyzed.Selecting aptamers against the background of pre-
viously selected aptamers, we could improve the affini- Aptamers that can bind to serine protease such as
a-thrombin and human neutrophil elastase have beenties of aptamers to NS3. Our studies on selected aptam-
ers revealed that G6–16 and G6–19 RNAs bound to the isolated. However, these aptamers did not inhibit the
proteolytic activities of these enzymes (Gold et al., 1995).protease domain of NS3 and inhibited its activity in vitro.
These aptamers were found to inhibit efficiently NS3 pro- To our knowledge, our isolated aptamers represent the
first example of aptamers that bind to and inhibit effi-tease activity. The aptamer G6–16 inhibited the proteo-
lytic activity in a mixed (competitive and noncompetitive) ciently the proteolytic activity of a peptidase that belongs
to the family of serine proteases. In addition, G6–16 andmanner with respect to the substrate. The inhibitory con-
centration required to inhibit 50% activity (Ki) of NS3 pro- G6–19 RNAs represent a class of molecule that showed
dual inhibitory function. Since these aptamers inhibit twotease was found to be 3 mM. The inhibitory constant of
the aptamer appears to be lower than those of aptamers important functions of NS3, they could prove to be useful
therapeutic agents. It would be interesting, next, to deter-that have been reported in the literature for other proteins
(Gold et al., 1995, and references therein). However, mine the effects of G6–16 or G6–19 aptamers on viral
replication in vivo.when this Ki is compared with the inhibitory concentra-
tions of known inhibitors of serine proteases such as
aprotinin, benzamidine, and chymostatin, the isolated ap- ACKNOWLEDGMENTS
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